| Literature DB >> 30390635 |
Albert Caballero-Solares1, Xi Xue2, Christopher C Parrish2, Maryam Beheshti Foroutani2, Richard G Taylor3, Matthew L Rise2.
Abstract
BACKGROUND: Dependence on marine natural resources threatens the sustainability of Atlantic salmon aquaculture. In the present study, Atlantic salmon fed for 14 weeks with an experimental diet based on animal by-products and vegetable oil (ABP) exhibited reduced growth performance compared with others fed a fish meal/fish oil based experimental diet (MAR) and a plant protein/vegetable oil-based experimental diet (VEG). To characterize the molecular changes underlying the differences in growth performance, we conducted a 44 K microarray study of the liver transcriptome of the three dietary groups.Entities:
Keywords: Aquaculture; Atlantic salmon; Cholesterol; Lipid composition; Liver transcriptome; Marine ingredients; Microarray; Nutrigenomics; Predictive biomarkers; Terrestrial ingredients
Mesh:
Substances:
Year: 2018 PMID: 30390635 PMCID: PMC6215684 DOI: 10.1186/s12864-018-5188-6
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Formulation (%) of the experimental diets fed to Atlantic salmon during the feeding trial and selected in the present and a previous study [28, 42]
| Ingredient (%)a | MAR | ABP | VEG |
|---|---|---|---|
| Fish meal | 34.5 | 5.0 | 5.0 |
| Poultry by-product mealsb | 14.6 | 33.3 | 10.3 |
| Corn gluten | 1.4 | 3.4 | 7.0 |
| Soy protein concentrate | 7.0 | 17.2 | 35.0 |
| Wheat gluten | 0.9 | 2.3 | 4.7 |
| Fish oil | 12.4 | 5.1 | 5.1 |
| Rapeseed oil | 6.2 | 14.4 | 17.3 |
| Raw wheat | 22.6 | 18.2 | 12.7 |
| Premixc | 0.5 | 1.1 | 3.0 |
| Total | 100.0 | 100.0 | 100.0 |
aAll ingredients were sourced from EWOS stocks
bFor confidentiality, the nature and proportions of the poultry by-product meals included in the diets are not provided
cPremix includes vitamins, trace elements and inorganic phosphorus. Composition in micronutrients of the premix is proprietary information to Cargill Innovation (formerly EWOS Innovation)
Growth parameters of the Atlantic salmon fed the three experimental diets
| Diet | MAR | ABP | VEG |
|---|---|---|---|
| Initial Weight (g) | 176.8 ± 29.4 | 179.2 ± 28.8 | 177.2 ± 29.8 |
| Final Weight (g) | 342.5 ± 89.5a | 316.3 ± 63.6b | 332.9 ± 79.2ab |
| Weight Gain1 (g) | 165.6 ± 77.5a | 137.1 ± 47.5b | 155.7 ± 64.6ab |
| HSI2 (%) | 1.49 ± 0.40a | 1.29 ± 0.38ab | 1.19 ± 0.25b |
| AFI3 (g fish− 1) | 178.7 ± 25.2 | 146.6 ± 5.5 | 167.4 ± 14.4 |
Values are expressed as mean ± standard deviation calculated from 134 to 138 individual fish of each dietary group for weight parameters, 29–32 fish for HSI, and 4 tanks of each dietary group for AFI. Different superscripts in the same row indicate significant differences among diets (one-way ANOVA, Tukey’s post-hoc test, p < 0.05)
1Weight gain = Final weight – Initial weight
2Hepatosomatic index = 100 × (liver mass/body mass)
3Apparent feed intake = feed consumption/number of fish per tank
List of microarray features representing genes involved in nutrient metabolism that were differentially expressed in the liver of Atlantic salmon fed diets with different proportions of marine and terrestrial ingredients
| Probe IDa | Best named BLASTx/BLASTn hit [species]b | Functional annotationc | ABP vs MARd | VEG vs MARd | VEG vs ABPd |
|---|---|---|---|---|---|
| Carbohydrate metabolism | |||||
| C035R008 |
| P: glycolytic process |
|
| 1.4 |
| C185R084 |
| P: fructose metabolic process |
| − 1.7 | 1.1 |
| C113R060 |
| P: fructose metabolic process | −1.7 |
| −1.1 |
| C043R025 | Fructose-bisphosphate aldolase B [ | P: glycolytic process | − 1.4 |
| − 1.3 |
| C169R002 |
| P: pentose-phosphate shunt, oxidative branch | −1.3 |
| − 1.6 |
| C039R032 |
| P: pentose-phosphate shunt, oxidative branch | −1.0 |
| − 1.7 |
| C128R035 | Predicted: glucose-6-phosphate 1-dehydrogenase-like (LOC106571947), transcript variant X3 [ | P: pentose-phosphate shunt, oxidative branch | −1.1 |
| − 1.3 |
| Lipid metabolism | |||||
| C134R089 |
| P: triglyceride biosynthetic process |
|
|
|
| C103R066 |
| P: triglyceride biosynthetic process | −1.3 |
| − 1.6 |
| C050R151 |
| P: fatty acid biosynthetic process | −1.3 |
|
|
| C086R144 |
| P: long-chain fatty acid transport | 1.2 |
|
|
| C262R025 |
| P: cholesterol biosynthetic process |
|
| 1.1 |
| C130R156 | Predicted: insulin-induced gene 1 protein-like [ | P: cholesterol biosynthetic process |
| 1.6 | −1.5 |
| C069R129 | Fatty acyl-CoA reductase 1 [ | P: glycerophospholipid biosynthetic process |
| 1.4 | −1.4 |
| C078R087 | Farnesyl pyrophosphate synthetase [ | P: cholesterol metabolic process |
| 1.8 | 1.0 |
| C229R065 |
| P: cholesterol biosynthetic process |
| 1.7 | −1.1 |
| C025R006 | Predicted: hydroxymethylglutaryl-CoA synthase, cytoplasmic-like (LOC106571543), transcript variant X4 [ | P: cholesterol biosynthetic process |
| 1.4 | −1.3 |
| C067R143 | Predicted: fatty acid hydroxylase domain-containing protein 2 [ | P: fatty acid biosynthetic process |
| − 1.4 | 1.6 |
| C089R080 | Predicted: apolipoprotein B-100 precursor [ | P: lipid transport |
| − 1.3 | 1.2 |
| C190R063 | Predicted: lipid phosphate phosphohydrolase 1 [ | P: lipid metabolic process | 1.7 |
| 1.3 |
| C188R006 | Predicted: long-chain-fatty-acid--CoA ligase ACSBG2 [ | P: long-chain fatty acid metabolic process | −1.7 |
| − 1.4 |
| C104R105 | Predicted: adiponectin precursor [ | P: fatty acid beta-oxidation; P: glucose homeostasis | −1.5 |
| − 1.3 |
| C085R162 | CCAAT/enhancer-binding protein alpha [ | P: lipid homeostasis; P:liver development | − 1.2 |
| − 1.5 |
| C004R046 | Predicted: fatty acid synthase [ | P: fatty acid biosynthetic process | −0.8 | −1.3 |
|
| Nucleotide metabolism | |||||
| C098R022 |
| P: ‘de novo’ AMP biosynthetic process |
|
| − 1.4 |
| C107R157 | Predicted: adenylosuccinate synthetase isozyme 1 C-like ( | P: ‘de novo’ AMP biosynthetic process |
|
| − 1.5 |
| C016R136 | Predicted: CTP synthase 1-like [ | P: ‘de novo’ CTP biosynthetic process | − 1.3 |
| − 1.7 |
| C086R065 | Predicted: kalirin-like isoform X6 [ | F: guanyl-nucleotide exchange factor activity | −1.2 | 1.7 |
|
aRefers to the identifier of the probe on the 44 K array
bThe contiguous sequences (contigs) from which the microarray probes were designed were used for gene identification by BLASTx against the NCBI nr database. The name of the protein [species] of the BLASTx hit with the lowest E-value (cutoff value of 10− 5) is presented. If no reliable BLASTx hits were found, the best BLASTn hit was chosen instead (E-value cutoff of 10− 10). BLASTn-identified genes are denoted with an asterisk. The names of those genes for which transcript levels were analyzed by real-time quantitative polymerase chain reaction (qPCR) are underlined. For the qPCR-analyzed genes, the gene symbol is indicated in brackets, differentiating paralogues if possible
cGene ontology (GO) terms selected to functionally annotate the cDNA’s best BLASTx/BLASTn hit, obtained from putative Danio rerio and Homo sapiens orthologues (i.e., best BLASTx hit from these model species). GO terms were obtained from UniProt Knowledgebase. GO categories: biological process (P), molecular function (F), and cellular component (C)
dFold-change (FC) values between two dietary treatments, calculated from microarray log2 ratios for a given probe (formula: 2A-B [55, 56]). Significant differences (PFP < 10%) between treatments are indicated by bolding the FC values
eqPCR primers were designed based on a cDNA sequence for Salmo salar 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4-like (BT044025), which shares 100% identity with the 60mer microarray probes. See Additional file 2 for additional information regarding BLASTx/BLASTn statistics and identity among the nucleotide sequences used for designing the microarray and qPCR probes
fAdssl1a and adssl1b paralogues showed 93% identity over 597 aligned nucleotides (see Additional file 3). Paralogue adssl1b was not qPCR-analyzed because none of the designed primer pairs passed quality testing due to low transcript levels (i.e., 10 ng of input total RNA yielding Ct values above 31)
List of microarray features representing genes involved in cellular processes that were differentially expressed in the liver of Atlantic salmon fed diets with different proportions of marine and terrestrial ingredients
| Probe IDa | Best named BLASTx/BLASTn hit [species]b | Functional annotationc | ABP vs MARd | VEG vs MARd | VEG vs ABPd |
|---|---|---|---|---|---|
| Protein synthesis and degradation | |||||
| C152R057 | Ribosomal protein L18a [ | P: translation |
| 1.6 | −1.3 |
| C027R084 | Predicted: trypsin-2 [ | P: proteolysis |
| 1.8 | −1.1 |
| C097R072 | Trypsin precursor [ | P: proteolysis |
| 1.2 | −1.6 |
| C172R121 | 60S ribosomal protein L7 [ | P: cytoplasmic translation; P: regulation of cell cycle |
| − 1.4 | 1.3 |
| C005R140 | 60S acidic ribosomal protein P2 [ | P: translational elongation | 1.9 |
| 1.2 |
| Cell growth and proliferation | |||||
| C168R030 |
| P: regulation of cell growth; P: regulation of cell proliferation |
| −1.1 |
|
| C050R117 |
| P: regulation of cell growth; P: regulation of cell proliferation |
| −1.2 | 1.4 |
| C231R170 |
| P: regulation of cell growth |
|
| −1.2 |
| C265R134 |
| P: regulation of cell growth |
|
| −1.1 |
| C170R142 |
| P: regulation of cell growth | −1.6 |
| − 1.1 |
| C035R053 | Predicted: BicC family RNA binding protein 1, transcript variant X7 [ | P: multicellular organism development | −1.4 |
| −1.1 |
| C064R045 | Predicted: PERQ amino acid-rich with GYF domain-containing protein 1-like [ | P: insulin-like growth factor receptor signaling pathway |
| 1.1 | −1.7 |
| C120R149 | Predicted: protein regulator of cytokinesis 1-like isoform X1 [ | P: positive regulation of cell proliferation |
| 1.5 | −1.3 |
| C087R056 | Pre-mRNA-splicing factor syf2 [ | P: positive regulation of cell proliferation |
|
| 1.3 |
| C240R016 | Predicted: cbp/p300-interacting transactivator 2-like [ | P: liver development; P:cell proliferation |
| −1.4 | 1.2 |
| Autophagy and apoptosis | |||||
| C241R134 | Predicted: serine/threonine-protein kinase ULK4 [ | P: regulation of p38MAPK cascade | 1.2 |
|
|
| C100R113 |
| P: positive regulation of apoptotic process |
| 1.3 | −1.5 |
| C263R103 | Predicted: G0/G1 switch protein 2-like [ | P: positive regulation of extrinsic apoptotic signaling pathway |
| −1.5 | 1.2 |
a,b,c,dAll column constructions are as described in Table 3
List of microarray features representing immune-related genes that were differentially expressed in the liver of Atlantic salmon fed diets with different proportions of marine and terrestrial ingredients
| Probe IDa | Best named BLASTx hit [species]b | Functional annotationc | ABP vs MARd | VEG vs MARd | VEG vs ABPd |
|---|---|---|---|---|---|
| Antibacterial | |||||
| C159R112 |
| P: response to bacterium |
|
|
|
| C134R121 |
| P: response to bacterium |
|
| 1.2 |
| C164R142 |
| P: response to bacterium |
| − 1.3 | 1.5 |
| C198R010 | Hepcidin-1 precursor [ | P: defense response to bacterium |
| −1.5 | 1.3 |
| C201R127 | Predicted: liver-expressed antimicrobial peptide 2-like [ | P: defense response to bacterium | −1.4 |
| −1.5 |
| C150R092 |
| P: defense response to bacterium |
| −1.2 |
|
| C061R085 |
| P: antibacterial humoral response | 1.2 | −1.3 |
|
| C205R051 |
| P: antibacterial humoral response | 1.2 | −1.3 |
|
| C075R137 |
| P: antibacterial humoral response | 1.2 | −1.3 |
|
| Antiviral | |||||
| C236R043 |
| P: immune system process, P: response to virus | 1.4 |
| 1.5 |
| C055R128 |
| P: immune system process, P: response to virus | −1.5 | 1.3 |
|
| Other immune-related | |||||
| C071R161 | Predicted: alpha-1-acid glycoprotein 1-like [ | P: regulation of immune system process |
| −1.4 | 1.6 |
| C097R069 |
| P: antigen processing and presentation | 1.1 |
| 1.7 |
| C027R162 |
| P: antigen processing and presentation | −1.3 |
| −1.3 |
| C211R164 |
| P: antigen processing and presentation | −1.1 | 1.7 |
|
| C243R111 |
| P: antigen processing and presentation | −1.3 | 1.5 |
|
| C219R002 | Predicted: glucosidase 2 subunit beta-like [ | P: innate immune response | −1.2 |
| −1.5 |
| C249R068 | Immunoglobulin light chain precursor [ | P: innate immune response | −1.0 | −1.8 |
|
| C238R071 | Predicted: C-C motif chemokine 13-like [ | P: chemotaxis; P: Inflammatory response | 1.0 | 1.8 |
|
| C012R162 | Predicted: dedicator of cytokinesis protein 11 isoform X2 [ | P: B cell homeostasis |
| 1.8 | −1.1 |
| C121R056 | Predicted: TSC22 domain family protein 3-like isoform X2 [ | P: negative regulation of activation-induced cell death of T cells |
| 1.2 | −1.4 |
| C255R144 | Ubiquitin [ | P: innate immune response | −1.4 | 1.4 |
|
| C219R041 | Predicted: peroxisomal membrane protein 2 [ | P: response to type I interferon | −1.4 | 1.3 |
|
| C050R077 | Predicted: probable E3 ubiquitin-protein ligase HERC6 [ | P: protein ubiquitination | −1.1 | 1.8 |
|
a,b,c,dAll column constructions are as described in Table 3
List of microarray features representing genes involved in oxidation-reduction processes that were differentially expressed in the liver of Atlantic salmon fed diets with different proportions of marine and terrestrial ingredients
| Probe IDa | Best named BLASTx hit [species]b | Functional annotationc | ABP vs MARd | VEG vs MARd | VEG vs ABPd |
|---|---|---|---|---|---|
| Oxidation-reduction process | |||||
| C163R079 | Predicted: bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial-like [ | P:folic acid metabolic process; P:oxidation-reduction process |
| 1.2 |
|
| C140R113 | Predicted: bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial-like [ | P:folic acid-containing compound biosynthetic process; P:oxidation-reduction process |
| 1.2 |
|
| C060R108 |
| P:aerobic respiration |
| −1.0 |
|
| C188R069 |
| P:aerobic respiration | 1.3 |
|
|
| C110R041 | Predicted: glycine dehydrogenase (decarboxylating), mitochondrial-like [ | P:glycine catabolic process; P:oxidation-reduction process |
| 1.4 | −1.4 |
| C177R075 | Predicted: 4-hydroxyphenylpyruvate dioxygenase-like protein [ | P:tyrosine catabolic process; P:oxidation-reduction process |
| 1.5 | −1.2 |
| C033R147 | Predicted: 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial-like [ | P:vitamin D catabolic process; P:oxidation-reduction process |
| 1.8 | −1.0 |
| C202R025 | Predicted: glutathione S-transferase theta-2B [ | P:glutathione metabolic process; P:oxidation-reduction process |
| −1.2 | 1.6 |
| C223R087 | Predicted: cytochrome c oxidase subunit 7A-related protein, mitochondrial [ | P:oxidation-reduction process | −1.5 |
| − 1.3 |
| C079R035 | Predicted: saccharopine dehydrogenase-like oxidoreductase [ | P:platelet degranulation P:oxidation-reduction process | −1.1 |
| − 1.5 |
| C161R028 | Cytochrome P450 1A1 [ | P:steroid metabolic process; P:oxidation-reduction process | −1.6 |
| − 1.2 |
| C013R125 | Predicted: phospholipid hydroperoxide glutathione peroxidase, mitochondrial-like isoform X2 [ | P:response to oxidative stress; P:oxidation-reduction process | 1.2 | −1.6 |
|
a,b,c,dAll column constructions are as described in Table 3
Fig. 1Scatter plot of gene expression fold-changes between diets calculated from the microarray log2 ratios and log2-transformed qPCR relative quantity (RQ) ratios. Each dot represents either an ABP vs MAR, VEG vs MAR, or VEG vs ABP comparison for a given gene
Fig. 2Results from the qPCR analysis of selected transcripts involved in carbohydrate (A: gck, pfkfb4, 6pgd), nucleotide (A: adssl1a), and lipid metabolism (A: acac, dgat2a, dgat2b; B: fabp3a, fabp3b, acox1, cpt1, acly, idi1, sqs). Columns and error bars represent mean relative quantity (RQ) values and S.E., respectively. Different letters above error bars represent significant differences between diets [one-way ANOVA, Tukey’s (homogeneity of variances among groups) or Games-Howell (variances not homogeneous across groups) post-hoc test, p < 0.05]. Gene abbreviations (below their corresponding columns) are according to UniProt terminology
Fig. 3Results from the qPCR analysis of selected transcripts involved in cell growth and proliferation (sgk2a, sgk2b, htra1a, htra1b), and apoptosis (gadd45ba, gadd45bb). Columns and error bars represent mean relative quantity (RQ) values and S.E., respectively. Different letters above error bars represent significant differences between diets [one-way ANOVA, Tukey’s (homogeneity of variances among groups) or Games-Howell (variances not homogeneous across groups) post-hoc test, p < 0.05]. Gene abbreviations (below their corresponding columns) are according to UniProt terminology
Fig. 4Results from the qPCR analysis of selected antibacterial (A: lect2a, lect2b, igma, igmb, igd), antiviral (B: mxa, mxb, ifit5), and other immune-related (A: mhcI) transcripts, as well as transcripts involved in oxidation-reduction processes (A: mtco1, mtco2a, mtco2b). Columns and error bars represent mean relative quantity (RQ) values and S.E., respectively. Different letters above error bars represent significant differences between diets [one-way ANOVA, Tukey’s (homogeneity of variances among groups) or Games-Howell (variances not homogenous across groups) post-hoc test, p < 0.05]. Gene abbreviations (below their corresponding columns) are according to UniProt terminology
Fig. 5Matrix representing Pearson’s correlation coefficients between log2-transformed RQs of the qPCR-analyzed transcripts (rows) and the log2-transformed levels of different lipid composition parameters (columns) in the liver of salmon fed the experimental diets. Significant differences among diets (one-way ANOVA, p < 0.05) are indicated on the right of the transcript abbreviations and below the phenotypic variables. Transcriptomic and phenotypic data were arranged based on a hierarchical clustering performed using Pearson correlation resemblance matrices (PRIMER, Version 6.1.15, Ivybridge, UK). Dendrograms next to transcript abbreviations and above lipid parameters represent the results of the hierarchical clustering analyses. EPA: eicosapentaenoic acid (20:5ω3); ARA: arachidonic acid (20:4ω6); SFA: saturated fatty acids; PUFA: polyunsaturated fatty acid; DHA: docosahexaenoic acid (22:6ω3)
Fig. 6Matrix representing Pearson’s correlation coefficients between log2-transformed RQs of hepatic transcripts (rows) and phenotypic features such as omega-3 and omega-6 FAs levels in muscle and weight gains (columns) of the salmon fed the experimental diets. Significant differences among diets (one-way ANOVA, p < 0.05) are indicated on the right of the transcript abbreviations and below the phenotypic variables. Transcriptomic and phenotypic data were arranged based on a hierarchical clustering performed using Pearson correlation resemblance matrices (PRIMER, Version 6.1.15, Ivybridge, UK). Dendrograms next to transcript abbreviations and above phenotypic parameters represent the results of the hierarchical clustering analysis. PUFA: polyunsaturated fatty acid; SFA: saturated fatty acids; DHA: docosahexaenoic acid (22:6ω3); EPA: eicosapentaenoic acid (20:5ω3); WG: weight gain; ARA: arachidonic acid (20:4ω6)
Results obtained from the stepwise discriminant analysis performed on log2-transformed qPCR-analyzed transcripts
| Grouping variable | Biomarkers included | Function | Eigenvaluea | Canonical correlationb | Wilks’ Lambdac | Accuracy (%)d | |||
|---|---|---|---|---|---|---|---|---|---|
| λ | χ2 | df | |||||||
| Diet (MAR, ABP, VEG) |
| 1 | 4.50 | 0.904 | 0.075 | 67.2 | 10 | < 0.001 | 90 |
| 2 | 1.41 | 0.765 | 0.415 | 22.9 | 4 | < 0.001 | |||
| Growth (High, Low) |
| 1 | 2.02 | 0.818 | 0.331 | 29.9 | 4 | < 0.001 | 94 |
| EPA + DHA (High, Low) |
| 1 | 0.394 | 0.532 | 0.717 | 7.98 | 2 | 0.019 | 67 |
aRatio between sum of squares among groups and within groups calculated from the discriminant scores of each function. Strong discriminant functions present eigenvalues above one
bMeasure of the association between the groups in the dependent variable (i.e., diet, growth, and EPA + DHA levels) and the discriminant function
cWilk’s lambda is used to test the significance of the discriminant functions
dAccuracy of the function(s) in predicting an individual’s membership to its corresponding phenotypic class